:: Volume 19, Issue 2 (6-2022) ::
J Res Dent Sci 2022, 19(2): 112-118 Back to browse issues page
Salivary interleukin 2 levels in patients with recurrent aphthous stomatitis during active ulcerative and healing period
Masoomeh Shirzaiy , Fatemeh Neshat
medical science , shirzaiy@gmail.com
Abstract:   (608 Views)
Background and Aim: Recurrent aphthous stomatitis(RAS) is one of the most common oral mucosal injuries. Various studies have shown Contradictory and varied results about inflammatory cytokines and the biological dimensions related to this complication.This study aimed to compare salivary interleukin-2 levels in patients with recurrent aphthous stomatitis (in the active ulcerative and healing periods) and healthy people.
Materials and methods: In this analytical and case-control study, unstimulated  saliva samples of  25 patients with recurrent aphthous stomatitis (case group) in the ulcerative and healing periods and 25 healthy individuals (control group) were collected  for assessment of interleukin-2 (IL-2) levels and transferred to the laboratory. Data were analyzed by SPSS 22 software and Independent t-test. Pvalue of lower than 0.05 was significant.
Results: IL-2 salivary levels in  RAS patients( 114.53 ± 93.48)  pg/ml and healthy controls (112.44 ±55.185)  had significantly difference (P˂0.001). Salivary IL-2 levels in RAS subjects in active ulcerative  (114.93 ± 53.48)  and healing periods ( 110.56 ±56.71) pg/ml  no significantly difference. (P˃0.05)
Conclusion: According to the results of the study, salivary IL-2  levels significantly increased  in RAS people in the active ulcerative , and healing periods compared to healthy controls. However, salivary Il-2 in  the active ulcerative , and healing periods  had no changing.
 
Article number: 3
Keywords: Recurrenr aphtous stomatitis, Interleukin-2, Saliv
Full-Text [PDF 284 kb]   (357 Downloads)    
Type of Study: original article | Subject: Oral Medicine



XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 2 (6-2022) Back to browse issues page